Contributing to SDGs 3, 5 and 16, this paper examines the demographic profile of female victims with intellectual disablities who were sexually assaulted and the characteristics of sexual assault.

Advancing SDGs 3, 5 and 16, this article discusses increased risk of family violence during COVID-19 pandemic and suggests that collaborations between human welfare and animal welfare agencies, expanding community partnerships, and informing the public of the great importance of reporting any concerns of abuse are all critical at this time.

This book chapter advances SDGs 3 and 5 by explaining that the use of a sex- and gender-based framework in the clinical practice of medicine will improve the care of both women and men, and likely have a positive impact on health outcomes.

This book chapter advances SDGs 3 and 5 by explaining that there is evidence that healthcare cost distress affects women disproportionately, and that one way clinicians can help combat the epidemic of financial toxicity is through the practice of high-value care, an approach that aims to improve patient health and well-being by reducing the costs of care and/or by improving patient outcomes.

This book chapter advances SDGs 3, 13, and 15 by explaining how particulate matter in our atmosphere can have a range of negative effects on the body when inhaled, emphasising the need to assess and improve air quality.

This chapter aligns with the SDG goal 3 of good health and wellbeing by examining the properties of the enzyme, hepatitis C NS2/3 protease, with special emphasis on the catalytic components of its active site, and the mechanism by which it hydrolyzes peptide bonds.

An article on the prevalence, risk factors, and management of dementia in older adults in China, in the context of SDG 3, highlighting the need for the development of a prevention strategy and optimising clinical management.

This book chapter advances SDGs 3 and 16 by examining three issues that are considered important public health issues as well as common patient problems—intimate partner violence, access to healthcare, and immunization—with a focus on sex and gender based medicine.

Animal models are used with increasing numbers in the late LO phase and particularly in the candidate selection phase for pharmacokinetic/pharmacodynamic (PK/PD) and efficacy, and then also used in regulatory required safety studies. Therefore, there are opportunities throughout the drug discovery process to incorporate more translationally predictive cellular models, or CIVMs, to both reduce animal use aligned to our 3Rs commitment (replacement, reduction, and refinement) and provide data that better translate to the clinic, which ultimately results in better medicines for patients.

This book chapter addresses SDGs 3 and 10 by explaining US and EU regulatory requirements, Global Food Safety Initiative requirements, and reviews food fraud vulnerabiility.